Clematis erecta extract inhibits migration, invasion and induce apoptosis in breast cancer cells
Abstract
Migration and invasion of breast cancer cells to distant parts of the body is a hallmark of the disease. The disease becomes difficult to manage and treat with an increased invasion by cancer cells. Some drugs kill the cancer cells but causes general cytotoxicity but no drugs are known to inhibit the invasive potential of cancer cells. Previously, the natural components have been proven to exhibit anticancer and invasive potential. Clematis erecta L. (Ranunculaceae) Leaves infusion is traditionally used to treat syphilitic, cancerous and other foul ulcers. Moreover, methanolic extract and and ethyl acetate fraction exhibited significant analgesic and anti-inflammatory activity. The scientific literature still lacks support for the anticancer potential of C. erecta. Therefore, it was envisaged to investigate the anticancer activities of C. erecta aerial parts on breast cancer cells. The results obtained suggest that C. erecta has anti-invasive potential on triple-negative human breast cancer cells (MDA-MB-231). Three different extracts (chloroform, methanol and water) of aerial parts of C. erecta were evaluated for their effect on the growth and migration of human breast cancer cells MDA-MB-231. Interestingly, aqueous extract inhibits cell growth by more than 50% and also inhibits migration and invasion by 40 and 50%, respectively. DNA fragmentation of extract treated cells further suggested that C. erecta has the potential to kill cancer cells.
Keywords:
Clematis erecta, migration, invasion, apoptosis, DNA fragmentation, RanunculaceaeDOI
https://doi.org/10.25004/IJPSDR.2023.150403References
WHO: World Health Organisation. Cancer: Fact sheet. 2020. (Online). Available: https://www.who.int/news-room/fact-sheets/detail/cancer
He L, Gu J, Lim LY, Yuan ZX, Mo J. Nanomedicine-mediated therapies to target breast cancer stem cells. Front Pharmacol 2016; 13 (7): 1-13.
Qin W, Huang G, Chen Z, Zhang Y: Nanomaterials in targeting cancer stem cells for cancer therapy. Front Pharmacol 2017; (8): 1-15.
Zhang LQ, Lv RW, Qu XD, Chen XJ, Lu HS, Wang Y. Aloesin suppresses cell growth and metastasis in ovarian cancer SKOV3 cells through the inhibition of the MAPK signaling pathway. Anal Cell Pathol 2017; 2017: 1-9.
UICC: The Union for International Cancer Control. Estimated number of new cases in 2020, worldwide, females, all ages. 2020. (Online) Available: https://www.uicc.org/news/globocan-2020-new-global-cancer-data.
Fehm T, Muller V, Alix-Panabieres C, and Pantel K: Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance. Breast Cancer Res. 2008; 1-10.
Goncalves A and Bertucci F. Clinical application of proteomics in breast cancer: state of the art and perspectives. Med Princ Pract. 2011; 20: 4–18.
Tomaskovic-Crook E, Thompson EW, and Thiery JP: Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res. 2009; 11: 213–223.
Radisky ES and Radisky DC. Matrix metalloproteinase-induced epithelial mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia. 2010; 15: 201–212.
Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003; 3: 362–374.
Geho DH, Bandle RW, Clair T, and Liotta LA. Physiological mechanisms of tumor-cell invasion and migration. Physiol. 2005; 20: 194–200.
Weber GF. Molecular mechanism of metastasis. Cancer Lett. 2008; (270): 181–190.
Luo M and Guan JL. Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett. 2009; 28: 127–139.
Xu Y, Bismar TA, Su J, Xu B, Kristiansen G. Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. J ExpMed. 2010; 207: 2421–2437.
Xu K, Rajagopal S, Klebba I, Dong S, Ji Y. The role of fibroblast Tiam1 in tumor cell invasion and metastasis. Oncogene. 2010; 29: 6533–6542.
Mareel M and Leroy A. Clinical, cellular and molecular aspects of cancer invasion. Physiol Rev. 2003; 83: 337-376.
Weng CJ and Yen GC. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev. 2012; 38: 76–87.
Clere N, Faure S, Martinez MC, Andriantsitohaina R. Anticancer properties of flavonoids: roles in various stages of carcinogenesis. Cardiovas Hematol Agents Med Chem. 2011; 9(2): 62–77.
Dai J, Mumper RJ. Plant phenolics: Extraction, analysis and their antioxidant and anticancer properties. Mol. 2010; 15: 7313-52.
Cragg GM and Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005; 100: 72-79.
Cragg GM, Grothaus PG and Newman DJ: Impact of natural products on developing new anti-cancer agents. Chem Rev. 2009; (109): 3012-3043.
Gowri SS, Pavitha S, Vasantha K. Free radical scavenging capacity and antioxidant activity of young leaves and barks of Acacia nilotica (L.) Del. Inter J Pharm Pharm Sci. 2011; 3(1): 160-164
Kiselova Y, Ivanova D, Chervenkov T, Gerova D, Galunska B, Yankova T. Correlation between the in vitro antioxidant activity and polyphenol content of aqueous extracts from bulgarian herbs. Phytother Res. 2006; 20(11): 961-965.
Chang HC, Chen ST, Chien SY, Kuo SJ, Tsai HT. Capsaicin may induce breast cancer cell death through apoptosis-inducing factor involving mitochondrial dysfunction. Hum Exp Toxicol. 2011; 30: 1657–1665.
Rana S, Rawat K, Mahendru M, Padwad Y, Pakade YB, Lal B, Bhushan S. Screening of bioconstituents and in vitro cytotoxicity of Clematis gouriana leaves. Nat Prod Res. 2015; 29(23): 2242-2246.
Li SG, Huang XJ, Li MM: Triterpenoid saponins from the roots of Clematis uncinata. Chem Pharm Bull 2014; 62 (1): 35–44.
Cheng L, Xia TS, Wang YF: The anticancer effect and mechanism of a-hederin on breast cancer cells. Inter J Oncol. 2014; 45 (2): 757–63.
Hao DC, Gu XJ, Xiao PG. Medicinal Plants. Woodhead Publishing Limited, 2015, pp. 341-371. https://doi.org/10.1016/B978-0-08-100085-4.00009-8.
Available: https://www.sciencedirect.com/science/article/pii/B9780081000854000098
Remington JP, Woods HC. The Dispensatory of the United States of America. Edn 20, The Southwest School of Botanical Medicine, 1918, pp. 124.
Chawla R, Kumar S, Sharma A. Pharmacognostic Standardization of Clematis erecta Linn. Int J Pharm Pharm Sci. 2012; 4 (1): 482- 87.
Madaus G, Schindler H. The influence of various fertilizers on the bactericidal and fungicidal effects of aqueous extracts of Clematis recta. Biol Zentralbl. 1936; 56: 167-173.
Kumar D and Kumar S: Screening of antianxiety activity of Abies pindrow Royle aerial parts. Indian J Pharm Educ Res. 2015; 49(1): 66-70.
Stockert JC, Blazquez -Castro A, Canete M, Horobin RW, Villanueva A. MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets. Acta Histochem. 2012; 114(8): 785-796.
Trusdell P, Ahn J, Chander H, Meens J, Watt K, Yang X, Craig AW. CIP4 promotes lung adenocarcinoma metastasis and is associated with poor prognosis. Oncogenes, 2015; 34(27): 3527-3535.
Chander H, Majumdar S, Sapru S, Rishi P. 55kDa outer-membrane protein from short-chain fatty acids exposed Salmonella enterica serovar Typhi induces apoptosis in macrophages. J Microbiol. 2006; 89 (3): 317–23.
Ghosh S. Cisplatin: The first metal based anticancer drug. Bioorg chem. 2019; 88: 102925.
Nussbaumer S, Bonnabry P, Veuthey JL, Fleury-Souverain S. Analysis of anticancer drugs: a review. Talanta. 2011; 85(5): 2265-2289.
Jin L, Chun J, Pan C, Li D, Lin R, Alesi GN, Wang X, Kang HB, Song L, Wang D, Zhang G. MAST1 drives cisplatin resistance in human cancers by rewiring cRaf-independent MEK activation. Cancer cell. 2018 Aug 13;34(2):315-330.
Upreti S, Pandey SC, Bisht I, Samant M. Evaluation of the target-specific therapeutic potential of herbal compounds for the treatment of cancer. Mol Divers. 2022; 26, 1823–1835.
Levitsky DO, Dembitsky VM. Anti-breast Cancer Agents Derived from Plants. Nat Prod Bioprospect. 2014; 5(1): 1-16.
Costa B, Amorim I, Gärtner F, Vale N. Understanding Breast cancer: from conventional therapies to repurposed drugs. Eur J Pharm Sci. 2020;151:105401.
Pipaliya BV, Trofimova DN, Grange RL, Aeluri M, Deng X, Shah K, Craig AW, Allingham JS, Evans PA. Truncated Actin-Targeting Macrolide Derivative Blocks Cancer Cell Motility and Invasion of Extracellular Matrix. J Am Chem Soc. 2021; 143(18):6847-6854.
Published
Abstract Display: 419 
PDF Downloads: 420 
